(G) Genpact - Ratings and Ratios

Exchange: NYSE • Country: Bermuda • Currency: USD • Type: Common Stock • ISIN: BMG3922B1072

Outsourcing, Analytics, Consulting, Automation, Finance

G EPS (Earnings per Share)

EPS (Earnings per Share) of G over the last years for every Quarter: "2020-09": 0.56, "2020-12": 0.51, "2021-03": 0.59, "2021-06": 0.66, "2021-09": 0.66, "2021-12": 0.54, "2022-03": 0.6, "2022-06": 0.7, "2022-09": 0.75, "2022-12": 0.7, "2023-03": 0.68, "2023-06": 0.72, "2023-09": 0.76, "2023-12": 0.82, "2024-03": 0.73, "2024-06": 0.72, "2024-09": 0.85, "2024-12": 0.91, "2025-03": 0.84, "2025-06": 0.88, "2025-09": 0,

G Revenue

Revenue of G over the last years for every Quarter: 2020-09: 935.523, 2020-12: 950.568, 2021-03: 946.071, 2021-06: 988.126, 2021-09: 1015.737, 2021-12: 1072.277, 2022-03: 1068.443, 2022-06: 1089.147, 2022-09: 1111.037, 2022-12: 1102.545, 2023-03: 1089.319, 2023-06: 1105.524, 2023-09: 1135.792, 2023-12: 1146.253, 2024-03: 1131.237, 2024-06: 1176.212, 2024-09: 1210.949, 2024-12: 1248.741, 2025-03: 1214.926, 2025-06: 1254.418, 2025-09: null,

Description: G Genpact November 03, 2025

Genpact Limited (NYSE:G) is a global provider of business-process outsourcing (BPO) and information-technology services, operating across North America, Latin America, Europe, India and the rest of Asia. The firm is organized into three verticals-Financial Services; Consumer & Healthcare; and High-Tech & Manufacturing-each delivering end-to-end solutions ranging from loan processing and compliance in finance to revenue-cycle management in health care and supply-chain engineering for manufacturers.

Based on FY 2023 results (the latest publicly disclosed figures), Genpact generated roughly **$4.0 billion** in revenue, with an **operating margin of ~12%** and a **year-over-year revenue growth of 12%** driven largely by digital-transformation contracts. The company’s **backlog**-the value of signed but un-delivered work-stood at about **$8 billion**, indicating a multi-year revenue runway. Client concentration remains modest, with the top 10 customers contributing less than **10%** of total revenue, which mitigates single-client risk.

Key macro-economic drivers for Genpact include the accelerating **outsourcing spend in regulated sectors** (especially financial services) as firms seek to meet expanding compliance burdens, and the broader **adoption of AI-enabled automation** that fuels demand for data-tech and CFO advisory services. Additionally, near-shoring trends in North America are prompting enterprises to shift non-core functions to specialized providers like Genpact, supporting a secular growth tail.

For a deeper, data-driven valuation framework, you might explore the detailed metrics on ValueRay.

G Stock Overview

Market Cap in USD 6,648m
Sub-Industry Data Processing & Outsourced Services
IPO / Inception 2007-08-02

G Stock Ratings

Growth Rating -13.6%
Fundamental 82.6%
Dividend Rating 56.5%
Return 12m vs S&P 500 -5.30%
Analyst Rating 3.91 of 5

G Dividends

Dividend Yield 12m 1.87%
Yield on Cost 5y 2.22%
Annual Growth 5y 11.78%
Payout Consistency 56.9%
Payout Ratio 25.2%

G Growth Ratios

Growth Correlation 3m -85.8%
Growth Correlation 12m -50%
Growth Correlation 5y -14.1%
CAGR 5y 0.90%
CAGR/Max DD 3y (Calmar Ratio) 0.03
CAGR/Mean DD 3y (Pain Ratio) 0.05
Sharpe Ratio 12m -0.55
Alpha -0.84
Beta 0.895
Volatility 25.43%
Current Volume 7042.7k
Average Volume 20d 1682.3k
Stop Loss 43.1 (-3.1%)
Signal 0.61

Piotroski VR‑10 (Strict, 0-10) 9.5

Net Income (538.3m TTM) > 0 and > 6% of Revenue (6% = 295.7m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA 1.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 15.07% (prev 23.28%; Δ -8.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 649.5m > Net Income 538.3m (YES >=105%, WARN >=100%)
Net Debt (868.3m) to EBITDA (880.0m) ratio: 0.99 <= 3.0 (WARN <= 3.5)
Current Ratio 1.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (177.1m) change vs 12m ago -2.13% (target <= -2.0% for YES)
Gross Margin 35.63% (prev 35.37%; Δ 0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 94.01% (prev 88.63%; Δ 5.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 9.98 (EBITDA TTM 880.0m / Interest Expense TTM 79.1m) >= 6 (WARN >= 3)

Altman Z'' 3.00

(A) 0.14 = (Total Current Assets 2.14b - Total Current Liabilities 1.39b) / Total Assets 5.31b
(B) 0.25 = Retained Earnings (Balance) 1.35b / Total Assets 5.31b
(C) 0.15 = EBIT TTM 789.0m / Avg Total Assets 5.24b
(D) 0.23 = Book Value of Equity 621.6m / Total Liabilities 2.72b
Total Rating: 3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 82.59

1. Piotroski 9.50pt = 4.50
2. FCF Yield 7.50% = 3.75
3. FCF Margin 11.43% = 2.86
4. Debt/Equity 0.59 = 2.33
5. Debt/Ebitda 0.99 = 1.79
6. ROIC - WACC (= 7.88)% = 9.85
7. RoE 21.92% = 1.83
8. Rev. Trend 93.33% = 7.00
9. EPS Trend -26.08% = -1.30

What is the price of G shares?

As of November 08, 2025, the stock is trading at USD 44.49 with a total of 7,042,691 shares traded.
Over the past week, the price has changed by +16.62%, over one month by +9.31%, over three months by +7.06% and over the past year by +7.98%.

Is Genpact a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Genpact (NYSE:G) is currently (November 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 82.59 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of G is around 40.66 USD . This means that G is currently overvalued and has a potential downside of -8.61%.

Is G a buy, sell or hold?

Genpact has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy G.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the G price?

Issuer Target Up/Down from current
Wallstreet Target Price 50.3 13.1%
Analysts Target Price 50.3 13.1%
ValueRay Target Price 45 1.2%

G Fundamental Data Overview November 04, 2025

Market Cap USD = 6.65b (6.65b USD * 1.0 USD.USD)
P/E Trailing = 12.6744
P/E Forward = 18.315
P/S = 1.3488
P/B = 2.7893
P/EG = 1.7
Beta = 0.895
Revenue TTM = 4.93b USD
EBIT TTM = 789.0m USD
EBITDA TTM = 880.0m USD
Long Term Debt = 833.4m USD (from longTermDebt, last quarter)
Short Term Debt = 525.0m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 868.3m USD (from netDebt column, last quarter)
Enterprise Value = 7.52b USD (6.65b + Debt 1.53b - CCE 663.3m)
Interest Coverage Ratio = 9.98 (Ebit TTM 789.0m / Interest Expense TTM 79.1m)
FCF Yield = 7.50% (FCF TTM 563.4m / Enterprise Value 7.52b)
FCF Margin = 11.43% (FCF TTM 563.4m / Revenue TTM 4.93b)
Net Margin = 10.92% (Net Income TTM 538.3m / Revenue TTM 4.93b)
Gross Margin = 35.63% ((Revenue TTM 4.93b - Cost of Revenue TTM 3.17b) / Revenue TTM)
Gross Margin QoQ = 35.88% (prev 35.31%)
Tobins Q-Ratio = 1.42 (Enterprise Value 7.52b / Total Assets 5.31b)
Interest Expense / Debt = 1.18% (Interest Expense 18.0m / Debt 1.53b)
Taxrate = 24.91% (44.0m / 176.7m)
NOPAT = 592.5m (EBIT 789.0m * (1 - 24.91%))
Current Ratio = 1.53 (Total Current Assets 2.14b / Total Current Liabilities 1.39b)
Debt / Equity = 0.59 (Debt 1.53b / totalStockholderEquity, last quarter 2.59b)
Debt / EBITDA = 0.99 (Net Debt 868.3m / EBITDA 880.0m)
Debt / FCF = 1.54 (Net Debt 868.3m / FCF TTM 563.4m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.14% (Net Income 538.3m / Total Assets 5.31b)
RoE = 21.92% (Net Income TTM 538.3m / Total Stockholder Equity 2.46b)
RoCE = 23.99% (EBIT 789.0m / Capital Employed (Equity 2.46b + L.T.Debt 833.4m))
RoIC = 15.61% (NOPAT 592.5m / Invested Capital 3.80b)
WACC = 7.73% (E(6.65b)/V(8.18b) * Re(9.31%) + D(1.53b)/V(8.18b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF Debug] Terminal Value 75.24% ; FCFE base≈521.9m ; Y1≈571.0m ; Y5≈725.2m
Fair Price DCF = 57.84 (DCF Value 10.08b / Shares Outstanding 174.3m; 5y FCF grow 10.74% → 3.0% )
EPS Correlation: -26.08 | EPS CAGR: -57.32% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.33 | Revenue CAGR: 4.51% | SUE: 0.99 | # QB: 1

Additional Sources for G Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle